1 Jun 2022 13:36
1 June 2022
DeepVerge PLC
("DeepVerge" or "the Company")
Skin Trust Club wins Best New Disrupter Brand at the Pure Beauty Global Awards 2022
Brand recognition gaining traction
DeepVerge Shanghai office re-opens post COVID-19 lockdowns
DeepVerge (LSE:DVRG.L) consumer skin test subsidiary brand Skin Trust Club has won the Best New Disrupter Brand award at the Pure Beauty Global Awards 2022. Now in its fifth year, the Pure Beauty Global Awards attracted over 500 entries from more than 40 countries across the globe and were judged by a panel of highly respected industry experts.
Skin Trust Club incorporates an artificial intelligence Skincare App and Home Test Kit that provide simple, at-home skin microbiome testing for personalised skincare and skin health tracking. The self-administered skin swab is a remote trial and allows the participant to conduct each stage of the trial without interaction. Skin Trust Club's test generates a report that consumers can use to manage their custom skincare regime. Analysis of skin attributes provides information to create hundreds of different product combinations to suit a person's unique skin microbiome.
Gerard Brandon, CEO of DeepVerge, comments:
"We are delighted to receive this award in recognition of the incredible pace at which Skin Trust Club has gained a strong global reputation of providing personalised daily skincare routine guidance based on our scientific heritage. People now recognise the importance of skin and want to understand how best to protect it. Through our app, members receive a report based on a single swab to find out their unique skin biome, in real-time, and within their environment, to empower and inform their choice of skincare routine. Skin Trust Club is truly the holy grail of scientific based skin care. This award clearly shows the demand which we only expect to grow over the coming year.
On another note, we are relieved that restrictions are easing in China and our office in Shanghai is back open for business. The team have continued their incredible work throughout the pandemic, and I would like to thank them for their commitment and dedication during these challenging times."
For further information please contact:
DeepVerge plc | Gerard Brandon, CEO
| +44 (0) 7340 055 648 |
SPARK Advisory Partners Limited (Nominated Adviser)
| Neil Baldwin/Andrew Emmott | +44 (0) 113 370 8974 |
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker/James Pope | +44 (0) 20 3657 0050 |
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.
Skin Trust Club
Skin Trust Club incorporates an artificial intelligence Skincare App and Home Test Kit that provide simple, at-home skin microbiome testing for personalised skincare and skin health tracking. The self-administered skin swab is a remote trial and allows the participant to conduct each stage of the trial without interaction. Skin Trust Club's DNA Test generates a report that consumers can use to manage their custom skincare regime. Analysis of skin attributes provides information to create hundreds of different product combinations to suit a person's unique skin microbiome.
Labskin (Life Science Division)
Labskin is a 3D human skin equivalent test platform that scientifically proves the impact of skincare product claims in healthcare, life sciences, skin microbiome clinical trials, pharmaceutical and cosmetics industries. Labskin have been pioneering the development of a laboratory grown human skin platform for 15 years and is the only commercially available lab-grown full thickness human skin model that naturally mimic the skins' microbiome. Labskin's virtual clinical trials with remote collection of human volunteers' skin microbiome provides a solution for the collection of volunteer microbiomes to allow for lab-controlled trials of advanced skin models and human microbiomes. As the data bank of remote volunteers grow, the higher the accuracy and increased reliability of virtual product testing that can be provided to clients, eliminating early human trial and error testing and resulting in a faster time to market. The Labskin test platform and protocols help clients maintain an optimum real-world environment, when testing their new ingredients and existing products, that shows the positive or negative impact on skin's natural microflora.
About Reach announcements
Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.